Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3927]

Progress and prospects of the EORTC

Prof Bertrand Tombal - Université catholique de Louvain, Brussels, Belgium

Progress and prospects of the EORTC ( Prof Bertrand Tombal - Université catholique de Louvain, Brussels, Belgium )

Gynaecological cancer: Where are we now?

Dr Nelleke Ottevanger - Radboud University Medical Center, Nijmegen, Netherlands

Gynaecological cancer: Where are we now? ( Dr Nelleke Ottevanger - Radboud University Medical Center, Nijmegen, Netherlands )

Assessing quality of life in clinical trials

Prof Mogens Grønvold - University of Copenhagen, Copenhagen, Denmark

Assessing quality of life in clinical trials ( Prof Mogens Grønvold - University of Copenhagen, Copenhagen, Denmark )

EORTC infrastructure: The road ahead

Dr Vassilis Golfinopoulos - European Organisation for Research and Treatment of...

EORTC infrastructure: The road ahead ( Dr Vassilis Golfinopoulos - European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium )

Sequencing Sorafenib and Regorafenib in advanced hepatocellular carcinoma –...

Prof Josep Llovet, Dr Richard Finn

Sequencing Sorafenib and Regorafenib in advanced hepatocellular carcinoma – Brought to you by Oncology Knowledge into Practice ( Prof Josep Llovet, Dr Richard Finn )

Outcome of men with relapses after adjuvant BEP for clinical stage I nonseminoma

Dr Stefanie Fischer - The Christie NHS Foundation Trust, Manchester, UK

Outcome of men with relapses after adjuvant BEP for clinical stage I nonseminoma ( Dr Stefanie Fischer - The Christie NHS Foundation Trust, Manchester, UK )

KEYNOTE-427 cohort B: First-line pembrolizumab monotherapy for advanced non...

Prof David McDermott - Beth Israel Deaconess Medical Center, Boston, USA

KEYNOTE-427 cohort B: First-line pembrolizumab monotherapy for advanced non-clear cell renal cell carcinoma ( Prof David McDermott - Beth Israel Deaconess Medical Center, Boston, USA )

Latest from CheckMate 650: Nivolumab plus ipilimumab for the treatment of...

Dr Sumit Subudhi - MD Anderson Cancer Center, Houston, USA

Latest from CheckMate 650: Nivolumab plus ipilimumab for the treatment of metastatic castration-resistant prostate cancer ( Dr Sumit Subudhi - MD Anderson Cancer Center, Houston, USA )

Updates from the BCON trial: Longterm outcomes of hypoxia modification in...

Dr Yee Pei Song - The Christie NHS Foundation Trust, Manchester, UK

Updates from the BCON trial: Longterm outcomes of hypoxia modification in bladder preservation ( Dr Yee Pei Song - The Christie NHS Foundation Trust, Manchester, UK )

Penile squamous cell carcinoma is genomically similar to other HPV-driven...

Dr Jad Chahoud - MD Anderson Cancer Center, Houston, USA

Penile squamous cell carcinoma is genomically similar to other HPV-driven tumours ( Dr Jad Chahoud - MD Anderson Cancer Center, Houston, USA )

CB-839 in combination with cabozantinib in patients with clear cell and...

Prof Funda Meric-Bernstam - MD Anderson Cancer Center, Houston, USA

CB-839 in combination with cabozantinib in patients with clear cell and papillary metastatic renal cell cancer ( Prof Funda Meric-Bernstam - MD Anderson Cancer Center, Houston, USA )

KEYNOTE-365 Cohort A: Pembrolizumab plus olaparib in docetaxel-pretreated...

Prof Evan Yu - Fred Hutchinson Cancer Research Center, Seattle, USA

KEYNOTE-365 Cohort A: Pembrolizumab plus olaparib in docetaxel-pretreated patients with mCRPC ( Prof Evan Yu - Fred Hutchinson Cancer Research Center, Seattle, USA )

More from ecancer